Portable medical device for real-time imaging in emergency and neurological care
→ Industrialized medical device
→ Proprietary, patented imaging technology
→ Entering clinical validation (Q4 2026)
→ Path to market entry in 2027
This data room provides key information to evaluate Rilemo and its upcoming Seed round.
This round is designed to complete clinical validation, reach market entry, and drive initial adoption.
It includes materials on product development, clinical and regulatory roadmap, market opportunity, and financial planning.
The Rilemo Team
Valentina Lidoni - CEO - valentina@rilemo.it
Nadim Conti - Chairman & CTO - nadim@rilemo.it
General
Company
Product
Market
Finance
Legal
This Data Room is provided to you by:
Rilemo S.r.l.
Via Don Sebastiano Colleoni 20, Robbiate (LC), 23899, Italy
EU VAT: IT 04187140134 - ATECO: 26.60.02
PEC: rilemo@legalmail.it
Disclaimer on Data Use
The information contained in this data room is provided solely for the purpose of evaluating a potential investment in Rilemo S.r.l. (VAT: IT04187140134) and does not constitute a binding offer or investment commitment. For any questions, contact legal@rilemo.it.
Made with Bullet